for immobilizing pediatric patients before radiation therapy session prompted use of hypofractionated RT, which enabled treatment to be completed in less duration. Dose prescribed in patients treated with radical intent was 36 gy/9 fractions in 2-3 weeks, which was equivalent to conventional 50 Gy/5 times per week fractionation. [18] Treatment abandonment as well as loss to follow-up has also been reported from other developing countries, [10, 19, 20] which could be attributed to no response/progressive disease in an advanced stage, inability to accept enucleation as form of treatment, inability to cope up with frequency of follow-up, illiteracy, poverty, and negligence.
To unearth grim situation, specifically in India, as per one retinoblastoma world statistical analysis, China recorded 1095 retinoblastoma patients in 2013 in 28 established Retinoblastoma Treatment Centers (RTB), while Pakistan showed 312 patients in 6 RTBs, while in India, 1730 patients took treatment in 11 RTBs. Various approaches for improvement in the management of retinoblastoma in developing countries [19] have been summarized in Figure 2 .
Conclusions
Data from this study show late diagnosis, leading to poor outcome for patients with advanced retinoblastoma, which is in accordance with data from other developing countries. Even though management of patients changed in accordance with changing standard of care over the decade, mortality remained high. Inequality in patient access to health care is the reality in India. This study underlines this well-known fact and brings forth strategies which can lead to improvement of this scenario.
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There are no conflicts of interest. Dear Editor, Pilomatrixomas are uncommon tumors, which arise due to uncontrolled proliferation of hair matrix cells. They are said to represent 0.001%-0.003% of all dermatopathologic specimens. [1] Head and neck is the most common site. PubMed data search shows no data on pilomatrixoma of the nasal cavity or paranasal sinuses. Hence, this is the first reported case of pilomatrixoma involving the nasal cavity and maxillary sinus.
A 34-year-old male patient presented with progressive nasal obstruction and mass in the left nasal cavity for the past 6 months. It was associated with rhinorrhea and hyposmia. There was no history of pain, fever, epistaxis, trauma, or nasal surgery. He was on fluticasone furoate nasal spray. On examination, a pale-pinkish mass was seen filling the left nasal cavity, extending up to the anterior nares, with ulcerations on the exposed surface [ Figure 1 ].
(Continue on page 202...)
It was firm, nontender, not bleeding on touch and was arising from the lateral wall. Posterior rhinoscopy showed pinkish mass at the left choana, rest is normal. Nasal endoscopy showed the deviation of the septum to the right side, and mass arising from the left middle meatus. Computed tomography (CT) showed homogenous mass filling left nasal cavity and left maxillary sinus, extending up to the choana. Under general anesthesia, the mass of 7.5 cm was excised endoscopically. Attachment to the posterior maxillary wall was removed with microdebrider. The histopathologic examination showed outer respiratory epithelium, below which was stratified squamous epithelium. It had large areas showing shadow cells, multinucleated giant cells, areas of calcifications, small clusters of basaloid cells with dense chronic inflammatory (lymphoplasmacytic) infiltration suggestive of nasal pilomatrixoma [ Figure 2 ]. The patient is on follow-up with no evidence of any recurrence. Pilomatrixoma or calcifying epithelioma of Malherbe is a benign tumor that arises from hair follicles, first described by Malherbe and Chenantais in 1880. [2] The term pilomatrixoma was coined by Forbis and Helwing in 1961. The most common site is the head and neck, followed by the limbs. Nose, however, is a very rare site. Since there are no hair follicles in the maxillary sinus, this case becomes an interesting one. Pilomatrixoma has a female preponderance. It is common in first two decades of life. The exact etiology of pilomatrixoma is still unknown. Mutation of the β-catenin gene and viral etiology are suggested. It presents as a slowly growing, painless subcutaneous or intradermal mass, which is firm and gritty to palpation and mobile. It can stretch the skin over it, producing a "tent sign." Their usual size ranges from 1 cm to 3 cm. However, here, it was quite large, 7.5 cm. They have an association with Gardner's syndrome, Myotonic dystrophy, Turners syndrome, and Xeroderma pigmentosum. In CT, sand-like or nodular calcifications may be seen. Malignant transformation occurs very rarely, termed as pilomatrix carcinoma. Jones et al. reported that only 16% of pilomatrixomas are accurately diagnosed clinically. [3] Treatment is complete excision, and recurrence is rare. Pilomatrixoma is a rare tumor of the hair follicles. This case adds a new site to this peculiar lesion, the nasal cavity and sinus.
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